生物活性 | |||
---|---|---|---|
描述 | Prostaglandin E2 (PGE2) is a potent inflammatory mediator that is generated by cyclooxygenase 2 (COX2) conversion of arachidonic acid. PGE2 was shown to stimulate progenitor proliferation in vitro in cell culture and intravenous injection of PGE on injured mice showed significant improvement in marrow recovery versus control animals[3]. PGE2 (0.1 mg/min, i.a.) increases renal blood flow. PGE2 produces a biphasic change in renal vascular resistance, vasodilatation starts at 0.01 mg/min and is maximal at about 3 mg/min, while at the highest dose used (20 mg/min) PGE2 induces renal vasoconstriction[4]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00791323 | - | Completed | - | - | |
NCT00347503 | Cataract | Phase 4 | Completed | - | United States, Pennsylvania ... 展开 >> Bucci Laser Vision Wilkes Barre, Pennsylvania, United States, 18702 收起 << |
NCT03507621 | - | Active, not recruiting | December 15, 2018 | Turkey ... 展开 >> Kahramanmaras Sutcu Imam Univercity Faculty of edicine Kahramanmaraş, Onikişubat, Turkey, 251/A 46040 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.84mL 0.57mL 0.28mL |
14.19mL 2.84mL 1.42mL |
28.37mL 5.67mL 2.84mL |
参考文献 |
---|